It's How Medicine Should Be®

Translate

French German Italian Portuguese Russian

Acute Lymphoblastic Leukemia Treatment Study for Child Patients

Clinical Trial Title: 
Treatment of patients with newly diagnosed standard risk B-precursor acute lymphoblastic leukemia (ALL) for patients aged 365 days to 10 years
Clinical Trial Protocol ID: 
10080902
Clinical Trial Investigator Name: 
Paul Kent, MD
Clinical Trial Area: 
Pediatric Cancers and Blood Disorders
Contact Phone: 
(312) 413-5654
Contact Name: 
Nitin Sane